RECRUITING

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

Description

The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.

Study Overview

Study Details

Study overview

The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.

CGM Dynamic Index (CDI) for Predicting Prediabetes in People With Cystic Fibrosis

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

Condition
Prediabetes
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Indiana University Health, University Hospital, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * CF individuals aged 12-55 years.
  • * CF without diabetes or with prediabetes (as defined by OGTT and HbA1c).
  • * Willing to use a continuous glucose monitoring system with compatible smart phone for glucose data collection.
  • * Pregnancy.
  • * History of transplant.
  • * Use of immunosuppressant drugs.
  • * Use of oral steroids or any medication known to interfere with glucose.
  • * Allergy to adhesives.
  • * Individuals with severe concurrent medical conditions that could confound glucose monitoring data (e.g., terminal illness, major organ failure).
  • * Conditions that may make unsafe for participants to do study or impair or confound the study at the discretion of the investigator

Ages Eligible for Study

12 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Study Record Dates

2026-07-30